Efficacy and Safety of Docetaxel Plus Oxaliplatin and Capecitabine in the First Line Treatment of Advanced Gastric Adenocarcinoma

Figure 1

Kaplan-Meier curves of progression-free survival (PFS, 197 days) and overall survival (OS, 364 days) of DOX regimen.